Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Oppenheimer Downgrades CinCor Pharma to Perform

Oppenheimer Downgrades CinCor Pharma to Perform

Oppenheimer analyst Jay Olson downgrades CinCor Pharma (NASDAQ:CINC) from Outperform to Perform.

byBenzinga Newsdesk

November 29, 2022

1 minute read

Oppenheimer analyst Jay Olson downgrades CinCor Pharma (NASDAQ:CINC) from Outperform to Perform.

News

“Toyota, Nissan And Honda To Team On AI And Chips For Next-Gen Cars” – Nikkei Asia

By Benzinga Newsdesk

May 16, 12:41 PM

https://asia.nikkei.com/Business/Automobiles/Toyota-Nissan-and-Honda-to-team-on-AI-and-chips-for-next-gen-carsToyota Motor, Nissan Motor, Honda Motor and other major Japanese automakers will work together to develop

HMC

Legal
News

Financial Industry Regulatory Authority Fines Bank Of America Unit $5M For Large Options Position Reporting Failures

By Benzinga Newsdesk

Yesterday, 10:40 AM

- Reuters

BAC

What’s Going On With Robinhood Stock Wednesday?

By Adam Eckert

November 8, 10:19 AM

Robinhood Markets Inc (NASDAQ: HOOD) shares are trading lower Wednesday on the heels of the company's third-quarter financial results.

HOOD

Morgan Stanley Upgrades RingCentral to Overweight, Lowers Price Target to $50

By Benzinga Newsdesk

December 14, 8:14 AM

Morgan Stanley analyst Meta Marshall upgrades RingCentral (NYSE:RNG) from Equal-Weight to Overweight and lowers the price target from $55 to $50.

RNG

Oppenheimer Downgrades CinCor Pharma to Perform

Related Posts

“Toyota, Nissan And Honda To Team On AI And Chips For Next-Gen Cars” – Nikkei Asia

Financial Industry Regulatory Authority Fines Bank Of America Unit $5M For Large Options Position Reporting Failures

What’s Going On With Robinhood Stock Wednesday?

Morgan Stanley Upgrades RingCentral to Overweight, Lowers Price Target to $50